Delivery Order SPE2DB20D2001-SPE2DB24FM36Y
- Not listed
- This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,435.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
- This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $15,786.67, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 9, 2024, with a completion date of May 10, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pen medication, valued at $1,993.76, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,813.92 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of November 7, 2024. This award is associated with a larger Indefinite...
- This federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pen medical products to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $53,966.86 and a completion date of February 15, 2024. The contract is a delivery order with a firm fixed price pricing type and was not set aside for any particular business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract, with a ceiling value of $1,756.32, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the company with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. The DLA, a defense agency, is the primary funding agency for this award, which does not...
- This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $8,424.72 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the...
- This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the U.S. government. The contract, valued at $3,599.86, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The...
- This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,176.72. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 11, 2025. This award is not designated as a set-aside contract, indicating open...
- This federal contract award is for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $24,225.11 firm fixed-price delivery order has an ultimate completion date of December 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM36YDelivery Order
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $7,302.24 and runs through December 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a delivery order under that larger IDC. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM.gov) and is a for-profit organization that specializes in distributing a wide range of pharmaceutical and medical products to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 12/26/23 |